The novel factor VIIa/tissue factor inhibitor, recombinant nematode anticoagulant protein C2, alters PT/INR in dose-dependent manner proportionate with plasma concentration in patients with nSTE-ACS: Data from the ANTHEM-TIMI 32 trial
Author Department
Medicine
Document Type
Presentations, Research
Publication Date
3-1-2008
Recommended Citation
Singh V, Wivott S, Simon D, Schweiger M, Leesar M, Stone P, Goulder M, Deitcher S, Giugliano R. The novel factor VIIa/tissue factor inhibitor, recombinant nematode anticoagulant protein C2, alters PT/INR in dose-dependent manner proportionate with plasma concentration in patients with nSTE-ACS: Data from the ANTHEM-TIMI 32 trial. Society for Cardiovascular Angiography and Interventions Annual Scientific Sessions in Partnership with ACC i2 Summit. Chicago, IL. Mar 29-Apr 1, 2008.
COinS